Formosa Biomedical Technology Corporation was founded on January 1st, 2004. To develop and manufacture high-tech, high quality, safe and healthy products by integrating three major resources of Formosa Group in manufacturing, academic studies and clinical research & services. In the mean time, to strengthen the core competency and shape "Formosa Biomedical Technology Corporation" as an international brand on the basis of our unique core technology, company culture and characteristics of products.
General Biologicals Corp. (GBC), founded in 1984, is the industry-leading in-vitro diagnostic device manufacturer in Taiwan. GBC is certified with IVD Class III, GMP and ISO 13485:2003. GBC has offices in Taipei, Hsin-Chu, Kaohsiung (Taiwan), Irvine (USA), and Vancouver (Canada). GBC has developed a wide spectrum of technology platform in various diagnostics products such as Raw Materials (antibody & antigen), Radioimmunoassay (RIA), Enzyme-linked Immunoassay (ELISA), Point-of-Care Test (POCT) and Real-Time Polymerase Chain Reaction (RT-PCR). In addition, GBC has its own intensive sequential vertical technology platform of hybridoma techniques, cell culture, genetic engineering, protein purification and peptide synthesis, assay, coating, fill-in and labeling.
Biohit Oyj is a globally operating Finnish biotechnology company. Biohit’s mission is “Innovating for Health” – we produce innovative products and services to promote research and early diagnosis. Biohit is headquartered in Helsinki, Finland, and has subsidiaries in Italy and the UK. Biohit's Series B share (BIOBV) is quoted on NASDAQ OMX Helsinki in the Small cap/Healthcare group.
Founded in Numazu, Shizuoka to launch businesses that cover the research and development of in vitro diagnostics (IVDs), research reagents and analytical reagents, and relevant system development.
nal von minden GmbH is a sales professionals, specialising in vitro diagnostic products for the European market. In the field of drug analysis and medical diagnosis, nal von minden provides a comprehensive and innovative range of products of the highest quality. The current portfolio includes rapid tests and ELISA tests for the areas of pediatrics, gynecology, urology, infectious diseases, bacteriology, serology and toxicology.
Hibergene Diagnostics is a Dublin-based, private Irish company, that develops, manufactures and markets molecular diagnostic tests for human infectious diseases, using the LAMP (Loop Mediated Isothermal Amplification) technology.